Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Bluefish Pharmaceuticals AB (publ)

Closing information (x1000 EUR)

Closing information 2023/04 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Turnover 47,700 Less Arrow 37,695 More Arrow 41,287
Financial expenses 3,635 Less Arrow 1,506 Less Arrow 852
Earnings before taxes -7,964 More Arrow -1,855 More Arrow 3,587
EBITDA -2,433 More Arrow 1,721
Total assets 47,755 More Arrow 55,554 Less Arrow 49,994
Current assets 36,336 More Arrow 44,773 Less Arrow 37,038
Current liabilities 17,892 More Arrow 44,686 Less Arrow 21,120
Equity capital -3,678 More Arrow 8,673 More Arrow 10,776
- share capital 1,906 More Arrow 2,111 More Arrow 2,150
Employees (average) 128 Less Arrow 124 More Arrow 129

Financial ratios

Fiscal year 2023/04 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Solvency -7.7% More Arrow 15.6% More Arrow 21.6%
Turnover per employee 373 Less Arrow 304 More Arrow 320
Profit as a percentage of turnover -16.7% More Arrow -4.9% More Arrow 8.7%
Return on assets (ROA) -9.1% More Arrow -0.6% More Arrow 8.9%
Current ratio 203.1% Less Arrow 100.2% More Arrow 175.4%
Return on equity (ROE) 216.5% Less Arrow -21.4% More Arrow 33.3%
Change turnover 13,654 Less Arrow -2,828 More Arrow 3,439
Change turnover % 40% Less Arrow -7% More Arrow 9%
Chg. No. of employees 4 Less Arrow -5 Less Arrow -20
Chg. No. of employees % 3% Less Arrow -4% Less Arrow -13%

Total value of public sale

Fiscal year 2023/04 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.